Commutability of control materials in glycohemoglobin determinations

Area of Science:

• Clinical Chemistry
• Analytical Chemistry
• Biomedical Science

Background:

• Glycohemoglobin (HbA1c) is a key biomarker for diabetes management.
• Accurate and consistent measurement across different laboratory methods is crucial.
• Intermethod variability can impact clinical decision-making and patient care.

Purpose of the Study:

• To compare the intermethod variability of control materials and patient blood samples for glycohemoglobin measurement.
• To evaluate the effectiveness of calibration using control materials for different analytical techniques.
• To assess the clinical utility of harmonized glycohemoglobin results.

Main Methods:

• Analysis of 50 patient blood samples and 15 control materials using High-Performance Liquid Chromatography (HPLC), affinity, and immunochemical methods.
• Calculation of normalized residuals to quantify method distances from regression lines.
• Characterization of control materials using total hemoglobin content, Hb derivatives, and cellulose acetate electrophoresis.

Main Results:

• A minority of control materials adequately simulated patient blood samples.
• Intermethod calibration primarily harmonized results for HPLC methods.
• Calibration of immunochemical techniques (Boehringer, Roche) failed to achieve clinically useful intermethod agreement.

Conclusions:

• Control materials may not accurately represent patient blood samples for glycohemoglobin analysis.
• HPLC methods demonstrate better potential for result harmonization through calibration.
• Immunochemical methods require further development to improve intermethod agreement for reliable clinical application.